Primary sclerosing cholangitis (PSC) is a rare, chronic cholestatic liver disease of uncertain etiology characterized by the destruction of the intrahepatic and/or extrahepatic ducts through ...

However, a recent randomized, controlled trial has surprisingly shown that the use of high-dose UDCA in patients with primary sclerosing cholangitis (PSC) may be harmful; adverse events ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Primary sclerosing cholangitis (PSC) is a rare progressive liver disease that damages bile ducts and significantly increases the risk of bile duct cancer, particularly a type called ...

Keith Lamont Cummings, the Chief Financial Officer of Pliant Therapeutics, Inc. (NASDAQ:PLRX), recently sold shares of the ...

Examples include primary sclerosing cholangitis, secondary sclerosing cholangitis and biliary atresia.

Mirum Pharmaceuticals Announces Preliminary Unaudited 2024 Net Product Sales and Cash Balance and Provides Corporate Updates ...

Causes of cirrhosis include metabolic dysfunction-associated steatotic liver disease (MASLD), hepatitis, long-term alcohol use, and primary sclerosing cholangitis. According to the National ...

Primary sclerosing cholangitis and autoimmune hepatitis occur in almost 5% of people with IBD. Autoimmune hepatitis is when your immune system attacks healthy cells in your liver. Primary ...

"In 2013, I was diagnosed with a rare autoimmune disease called primary sclerosing cholangitis, which has no known treatment until you enter end-stage liver disease," he explained. Galbenski said ...

He has been battling PSC, or primary sclerosing cholangitis, for the past 30 years. In the midst of a battle with life-threatening liver disease, former NHL player Steve Ludzik’s family has put ...